{"count": 9, "results": [{"_id": "37298689", "pmid": 37298689, "pmcid": "PMC10253741", "title": "Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells", "journal": "Int J Mol Sci", "authors": ["Lee YG", "Chou FN", "Tung SY", "Chou HC", "Ko TL", "Fann YC", "Juan SH"], "date": "2023-06-04T00:00:00Z", "doi": "10.3390/ijms24119738", "meta_date_publication": "2023 Jun 4", "meta_volume": "24", "meta_issue": "11", "meta_pages": "", "score": 50288.94, "text_hl": "We evaluated the potential anti-@<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@ccRCC@@@ effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Lee YG, Chou FN, Tung SY, Chou HC, Ko TL, Fann YC, Juan SH. Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells Int J Mol Sci. 2023 Jun 4;24(11):. PMID: 37298689", "BibTeX": "@article{37298689, title={Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells}, author={Lee YG and Chou FN and Tung SY and Chou HC and Ko TL and Fann YC and Juan SH}, journal={Int J Mol Sci}, volume={24}, number={11}}"}}, {"_id": "36431025", "pmid": 36431025, "pmcid": "PMC9695258", "title": "Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells", "journal": "Life (Basel)", "authors": ["Chen TC", "Huang CW", "Lo CY", "Chen CN", "Chang SF", "Chen YY"], "date": "2022-11-15T00:00:00Z", "doi": "10.3390/life12111890", "meta_date_publication": "2022 Nov 15", "meta_volume": "12", "meta_issue": "11", "meta_pages": "", "score": 50279.766, "text_hl": "The @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxic@@@ mechanism of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@ cells may provide a new strategy to improve therapeutic outcomes for the @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@ treatment.", "citations": {"NLM": "Chen TC, Huang CW, Lo CY, Chen CN, Chang SF, Chen YY. Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells Life (Basel). 2022 Nov 15;12(11):. PMID: 36431025", "BibTeX": "@article{36431025, title={Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells}, author={Chen TC and Huang CW and Lo CY and Chen CN and Chang SF and Chen YY}, journal={Life (Basel)}, volume={12}, number={11}}"}}, {"_id": "33517812", "pmid": 33517812, "title": "Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5.", "journal": "Scand J Urol", "authors": ["Qiu Y", "Zhao Y", "Wang H", "Liu W", "Jin C", "Xu W"], "date": "2021-08-01T00:00:00Z", "doi": "10.1080/21681805.2021.1876163", "meta_date_publication": "2021 Aug", "meta_volume": "55", "meta_issue": "4", "meta_pages": "337-343", "score": 50262.277, "text_hl": "Our aim was to evaluate the inhibitory effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@. ", "citations": {"NLM": "Qiu Y, Zhao Y, Wang H, Liu W, Jin C, Xu W. Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5. Scand J Urol. 2021 Aug;55(4):337-343. PMID: 33517812", "BibTeX": "@article{33517812, title={Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5.}, author={Qiu Y and Zhao Y and Wang H and Liu W and Jin C and Xu W}, journal={Scand J Urol}, volume={55}, number={4}, pages={337-343}}"}}, {"_id": "31071981", "pmid": 31071981, "pmcid": "PMC6539125", "title": "Simvastatin Attenuates H2O2-Induced Endothelial Cell Dysfunction by Reducing Endoplasmic Reticulum Stress", "journal": "Molecules", "authors": ["He Z", "He X", "Liu M", "Hua L", "Wang T", "Liu Q", "Chen L", "Yan N"], "date": "2019-05-08T00:00:00Z", "doi": "10.3390/molecules24091782", "meta_date_publication": "2019 May 8", "meta_volume": "24", "meta_issue": "9", "meta_pages": "", "score": 50068.48, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Attenuates @CHEMICAL_Hydrogen_Peroxide @CHEMICAL_MESH:D006861 @@@H2O2@@@-Induced Endothelial @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@Cell Dysfunction@@@ by Reducing Endoplasmic Reticulum Stress", "citations": {"NLM": "He Z, He X, Liu M, Hua L, Wang T, Liu Q, Chen L, Yan N. Simvastatin Attenuates H2O2-Induced Endothelial Cell Dysfunction by Reducing Endoplasmic Reticulum Stress Molecules. 2019 May 8;24(9):. PMID: 31071981", "BibTeX": "@article{31071981, title={Simvastatin Attenuates H2O2-Induced Endothelial Cell Dysfunction by Reducing Endoplasmic Reticulum Stress}, author={He Z and He X and Liu M and Hua L and Wang T and Liu Q and Chen L and Yan N}, journal={Molecules}, volume={24}, number={9}}"}}, {"_id": "27042994", "pmid": 27042994, "title": "Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.", "journal": "Nutr Cancer", "authors": ["Woschek M", "Kneip N", "Jurida K", "Marzi I", "Relja B"], "date": "2016-01-01T00:00:00Z", "doi": "10.1080/01635581.2016.1152383", "meta_date_publication": "2016", "meta_volume": "68", "meta_issue": "3", "meta_pages": "420-7", "score": 50058.945, "text_hl": "Previous studies have indicated the anticancerous effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. Here, we evaluated the anticancerous potential of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@renal cell carcinoma@@@ (@<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@) cell lines. ", "citations": {"NLM": "Woschek M, Kneip N, Jurida K, Marzi I, Relja B. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway. Nutr Cancer. 2016;68(3):420-7. PMID: 27042994", "BibTeX": "@article{27042994, title={Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.}, author={Woschek M and Kneip N and Jurida K and Marzi I and Relja B}, journal={Nutr Cancer}, volume={68}, number={3}, pages={420-7}}"}}, {"_id": "23690956", "pmid": 23690956, "pmcid": "PMC3656850", "title": "Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway", "journal": "PLoS One", "authors": ["Fang Z", "Tang Y", "Fang J", "Zhou Z", "Xing Z", "Guo Z", "Guo X", "Wang W", "Jiao W", "Xu Z", "Liu Z"], "date": "2013-05-17T00:00:00Z", "doi": "10.1371/journal.pone.0062823", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "5", "meta_pages": "e62823", "score": 50058.805, "text_hl": "We also examined the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on cell colony formation of the @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@ cells. ", "citations": {"NLM": "Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, Guo X, Wang W, Jiao W, Xu Z, Liu Z. Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway PLoS One. 2013;8(5):e62823. PMID: 23690956", "BibTeX": "@article{23690956, title={Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway}, author={Fang Z and Tang Y and Fang J and Zhou Z and Xing Z and Guo Z and Guo X and Wang W and Jiao W and Xu Z and Liu Z}, journal={PLoS One}, volume={8}, number={5}, pages={e62823}}"}}, {"_id": "30872677", "pmid": 30872677, "pmcid": "PMC6418087", "title": "Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation", "journal": "Sci Rep", "authors": ["Chang CC", "Huang KH", "Hsu SP", "Lee YG", "Sue YM", "Juan SH"], "date": "2019-03-14T00:00:00Z", "doi": "10.1038/s41598-019-40757-6", "meta_date_publication": "2019 Mar 14", "meta_volume": "9", "meta_issue": "1", "meta_pages": "4606", "score": 50055.76, "text_hl": "The therapeutic effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@renal cell carcinoma@@@ (@<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@RCC@@@) are controversial. ", "citations": {"NLM": "Chang CC, Huang KH, Hsu SP, Lee YG, Sue YM, Juan SH. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation Sci Rep. 2019 Mar 14;9(1):4606. PMID: 30872677", "BibTeX": "@article{30872677, title={Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation}, author={Chang CC and Huang KH and Hsu SP and Lee YG and Sue YM and Juan SH}, journal={Sci Rep}, volume={9}, number={1}, pages={4606}}"}}, {"_id": "28011476", "pmid": 28011476, "title": "YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.", "journal": "Anticancer Res", "authors": ["Nitta T", "Koike H", "Miyao T", "Miyazawa Y", "Kato H", "Furuya Y", "Sekine Y", "Suzuki K"], "date": "2017-01-01T00:00:00Z", "doi": "10.21873/anticanres.11291", "meta_date_publication": "2017 Jan", "meta_volume": "37", "meta_issue": "1", "meta_pages": "75-80", "score": 50054.45, "text_hl": "MATERIALS AND METHODS: We induced @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ resistance in a @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@renal clear cell carcinoma@@@ cell line (@CELLLINE_CVCL:0234 @@@Caki-1-staR@@@). ", "citations": {"NLM": "Nitta T, Koike H, Miyao T, Miyazawa Y, Kato H, Furuya Y, Sekine Y, Suzuki K. YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin. Anticancer Res. 2017 Jan;37(1):75-80. PMID: 28011476", "BibTeX": "@article{28011476, title={YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.}, author={Nitta T and Koike H and Miyao T and Miyazawa Y and Kato H and Furuya Y and Sekine Y and Suzuki K}, journal={Anticancer Res}, volume={37}, number={1}, pages={75-80}}"}}, {"_id": "31432100", "pmid": 31432100, "pmcid": "PMC6713427", "title": "Simvastatin promotes endothelial dysfunction by activating the Wnt/beta-catenin pathway under oxidative stress", "journal": "Int J Mol Med", "authors": ["He Z", "Du X", "Wu Y", "Hua L", "Wan L", "Yan N"], "date": "2019-10-01T00:00:00Z", "doi": "10.3892/ijmm.2019.4310", "meta_date_publication": "2019 Oct", "meta_volume": "44", "meta_issue": "4", "meta_pages": "1289-1298", "score": 50048.527, "text_hl": "At a high dose (1 microM), @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ exacerbated @CHEMICAL_Hydrogen_Peroxide @CHEMICAL_MESH:D006861 @@@H2O2@@@-induced endothelial @<m>DISEASE_Carcinoma_Renal_Cell</m> @DISEASE_MESH:D002292 @@@cell@@@ dysfunction. ", "citations": {"NLM": "He Z, Du X, Wu Y, Hua L, Wan L, Yan N. Simvastatin promotes endothelial dysfunction by activating the Wnt/beta-catenin pathway under oxidative stress Int J Mol Med. 2019 Oct;44(4):1289-1298. PMID: 31432100", "BibTeX": "@article{31432100, title={Simvastatin promotes endothelial dysfunction by activating the Wnt/beta-catenin pathway under oxidative stress}, author={He Z and Du X and Wu Y and Hua L and Wan L and Yan N}, journal={Int J Mol Med}, volume={44}, number={4}, pages={1289-1298}}"}}]}